Patryk Gorniak
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL).
Journal: Cell death & disease
Published: July 31, 2025
Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
Journal: European journal of haematology
Published: August 26, 2020
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Journal: Scientific reports
Published: March 02, 2020
Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells.
Journal: Cancers
Published: February 04, 2020
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Journal: Cell death & disease
Published: January 29, 2020
BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells.
Journal: Molecular oncology
Published: November 18, 2019
Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia.
Journal: Cancers
Published: November 02, 2019
Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.
Journal: Journal of cellular and molecular medicine
Published: October 02, 2017
Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.
Journal: Oncotarget
Published: March 24, 2017
Last Updated: 09/26/2026